Tobacco Use Cessation Clinical Trial
Official title:
Comparative Evaluation of Efficacy of Different Methods of Tobacco Cessation Interventions Among BEST Employees in Mumbai : A Randomized Controlled Trial
Tobacco use is the single most preventable cause of premature adult death globally. It is one
of the major causes of death and disease in India, accounting for nearly 0.9 million deaths
every year.
Bombay Electric Supply and Transport (BEST), one of the biggest public transport undertaking
in Mumbai City, has imposed a ban on tobacco use in public transport buses and under Motor
Vehicle Act has empowered the drivers and bus conductors to take suitable action against
commuters found to be using tobacco. However in addition to commuters using tobacco in the
BEST premises, large number of bus drivers and conductors are known to use tobacco on the
job. There are various approaches to a tobacco cessation programme, like behavioural therapy,
pharmacotherapy, providing self help material, telephone counseling, quit lines etc.
Hence in terms of the workplace environment, understanding the factors leading to tobacco use
maintenance and the effective approaches for cessation is of critical importance for
formulating workplace tobacco prevention and cessation interventions that are applicable to
transport work employee settings. The success of these methods needs to be comparatively
evaluated among the different forms of tobacco users. Hence, the present study will be
undertaken with the following objectives:
RESEARCH OBJECTIVES:
1. To study the Knowledge, Attitudes and Practices (KAP) regarding tobacco among BEST
employees in Mumbai
2. To study the occupational correlates of tobacco consumption across various grades of
BEST employees
3. To educate them regarding hazards of tobacco.
4. To offer BEST employees Preventive Oncology screening facilities and evaluate the
compliance for screening and determine the rate of oral pre-cancers.
5. To study the post-intervention KAP regarding tobacco
6. To randomly assign the BEST employees using tobacco to one of the four tobacco cessation
interventions and study the compliance to the same.
7. To determine the rate of tobacco cessation after twelve months of follow-up.
8. To comparatively evaluate the success of the four approaches of tobacco cessation, viz.
providing self help material, telephone counseling, behavioural therapy and behavioural
+ pharmacotherapy, among users of different forms of tobacco.
Methodology:
Study Design: Four arm interventional study
Step 1: Around 4000 BEST employees in Mumbai will be enrolled after explaining the programme
and obtaining informed consent. They will be interviewed with the help of a well structured
questionnaire to collect information about their Knowledge, Attitudes and Practices (KAP)
regarding tobacco, their attitudes and experiences regarding smoke free public places with
specific reference to smoke free BEST buses.
Step 2: The BEST employees will be given detailed health education regarding hazards of
tobacco and the need for smoke free BEST buses. The BEST employees will be invited to
participate in Preventive Oncology (PO) screening (mainly oral cancer screening).
Step 3: The BEST employees will be again interviewed with the help of a well structured
questionnaire to collect information of their post-intervention KAP regarding tobacco and
smoke free public places.
Step 4: The BEST employees using tobacco will be registered at the Tobacco cessation clinic
and will be invited to participate in the first session of tobacco cessation counseling.
The BEST employees using smoking forms of tobacco will be offered interventions and will be
followed up as per the TCC protocol.
The smokeless tobacco users will be randomly assigned into one of the four groups to receive
intervention. Each group of employee will receive one of the four interventions as follows:
self help material, telephone counseling, behavioural therapy and behavioural +
pharmacotherapy.
The pharmacotherapy intervention in the form of Nicotine Replacement Therapy comprising of
Nicotine chewing gums or patches (Transdermal patches) will be based on individual need
assessment to relieve withdrawal symptoms in tobacco users when trying to quit.
Nicotine Chewing Gums:
Dose: 2 mg/4 mg, 10-15 pieces per day with maximum dose of 24 pieces/day depending on
cravings Total Duration: 12 weeks Duration of treatment: Higher dose for 4-6 weeks, with
weaning till 2-3 months Side effects: Bad taste, Throat irritation, burning in mouth, nausea,
vomiting, hiccups, increased heart beat etc
Nicotine Transdermal patches:
Dose: 7 mg/10 mg/14 mg/21 mg -for 24-hours use. Total Duration: 12 weeks Duration of
treatment: Higher strength patch for 2 weeks and depending on cravings will be gradually
decreased till 4 weeks Side effects: Skin irritation, dizziness, sleep problems, increased
heart beat etc
Step 5: The BEST employees with lesions will be followed up at the Preventive Oncology
screening clinic as per PO protocols. The tobacco users enrolled in the TCC will be followed
up over a period of twelve months with three interventions in between and a post-intervention
follow-up.
Variables to be estimated:
1. Knowledge, Attitudes and Practices (KAP) regarding tobacco among BEST employees.
2. The compliance for availing the services at Preventive Oncology screening facilities and
Tobacco cessation clinic at the Tata Memorial Hospital
3. The rate of oral pre-cancers among BEST employees.
4. The post-intervention KAP regarding tobacco.
5. The rate of tobacco cessation after one year follow-up.
6. Compare the success of various approaches for tobacco cessation and assess the
compliance for the same.
Data Analysis:
Data entry will be done in the Department of Preventive Oncology, Tata Memorial Hospital
using Statistical Package for Social Sciences (SPSS) version 18. Checks for consistency, data
safety and analysis will be carried out at regular intervals. Both descriptive and
inferential statistics will be generated for describing variables under the study objectives.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06021652 -
Feasibility, Adoption and Efficacy of A Virtual Reality Smoking Cessation Program for Patients Undergoing Lung Cancer Screening
|
N/A | |
Completed |
NCT02735382 -
EHR-Based and Fax-Based Referral to a Tobacco Quitline: A Comparative Study
|
N/A | |
Completed |
NCT02557919 -
Families Reduce Exposure to Smoke at Home
|
N/A | |
Completed |
NCT01570595 -
Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV
|
Phase 1/Phase 2 | |
Completed |
NCT00786149 -
Improving Varenicline Adherence and Outcomes in Homeless Smokers
|
Phase 3 | |
Completed |
NCT00387946 -
Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)
|
Phase 3 | |
Completed |
NCT00218452 -
Smoking Cessation for Young Adults Who Binge Drink - 1
|
Phase 0 | |
Completed |
NCT00124683 -
Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1
|
Phase 2 | |
Recruiting |
NCT04610931 -
Study of the Effectiveness of a Virtual Reality Treatment in the Management of Smoking Cessation
|
N/A | |
Enrolling by invitation |
NCT06042361 -
Enhancing Equity in Smoke-free Housing
|
N/A | |
Recruiting |
NCT04994444 -
Preloading With Nicotine Replacement Therapy in HIV-positive Smokers to Improve Self-Efficacy and Quit Attempts
|
Phase 2/Phase 3 | |
Recruiting |
NCT04827420 -
Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion)
|
N/A | |
Completed |
NCT05560243 -
Tobacco Cessation Tailored to Patients Living With HIV (PLWH) in Brazil
|
N/A | |
Completed |
NCT02721082 -
Changing the Default for Tobacco Treatment
|
Phase 4 | |
Completed |
NCT01885221 -
A Multi-Media Approach to Partner Support in Smokeless Tobacco Cessation (UCare-ChewFree)
|
N/A | |
Completed |
NCT03445507 -
Effectiveness of a Chat Bot for Smoking Cessation: a Pragmatic Trial in Primary Care.
|
N/A | |
Completed |
NCT04540081 -
Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer
|
N/A | |
Completed |
NCT03714191 -
Optimizing the Tobacco Cessation Clinical Decision Support Tool.
|
||
Completed |
NCT03553992 -
An Extended Facebook Intervention for Young Sexual and Gender Minority Smokers
|
N/A | |
Completed |
NCT01699828 -
Exploring Occupancy of Dopamine D3 Receptor by Buspirone in Humans Using PET
|
Phase 1/Phase 2 |